Results 211 to 220 of about 545,238 (360)
This perspective provides an overview of the growing interest in utilizing various gasotransmitters—small gaseous signaling molecules namely nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S)—for several therapeutic applications, with emphasis on the potential use of porous materials as carriers to provide safe and controlled local ...
Rosana V. Pinto+2 more
wiley +1 more source
Nanoparticulated Anti-Programmed Cell Death-1 Antibody Improves Localized Immune Checkpoint Blockade Therapy. [PDF]
Mujahid K+4 more
europepmc +1 more source
Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq+4 more
wiley +1 more source
Enhancing the potency of CAR-T cells against solid tumors through transcription factor engineering. [PDF]
Chen R+7 more
europepmc +1 more source
A phosphodiester‐backboned bottlebrush polymer (pacDNA) engineered for aptamer delivery is presented. This design enhances aptamer stability, plasma pharmacokinetics, and target engagement in vivo. In AXL‐driven cancer models, pacDNA inhibits AXL signaling and reduces tumor growth, highlighting the promise of precision polymer scaffolds in aptamer ...
Tingyu Sun+13 more
wiley +1 more source
Improvement of the Anticancer Efficacy of PD-1/PD-L1 Blockade: Advances in Molecular Mechanisms and Therapeutic Strategies. [PDF]
Gao P+7 more
europepmc +1 more source
Studies on the Antitumor Activity of Polysaccharide Produced by a Strain of Crepidotus sp.
Hiroshi NAKAYOSHI
openalex +2 more sources
This research introduces a cold plasma‐based platform for treating breast cancer bone metastases. Using a novel bioprinted 3D tumor‐stroma model, it highlights the selective antitumor effects of plasma‐generated reactive species. The platform aims to advance non‐invasive therapeutic strategies, offering potential clinical applications in controlling ...
Laura M. Bouret+4 more
wiley +1 more source
Boosting cancer immunotherapy: drug delivery systems leveraging ferroptosis and immune checkpoint blockade. [PDF]
Zhang T+5 more
europepmc +1 more source
An overview: Antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition [PDF]
María Elena Flores+4 more
openalex +1 more source